Visual branding. We all know it's crucial. Some of us think we have it down. But are we confident our branding is truly driving growth?
Join us for a 1.5-hour workshop with Krishna Solanki.
Krishna will share insights from her extensive experience creating visual brand identities, covering what makes a strong visual identity, why consistency matters, and how to maintain it across all platforms.
About Healx
Pioneer Group, the specialist life science infrastructure and venture-building company, welcomed 425 school children from 29 schools to eight of its sites across the UK this week to mark Ada Lovelace Day, an international celebration of the achievements of women in STEM.
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
Function, Focus area, Location
Conserva UK will also be on site at the Babraham Research Campus, Cambridge on Thursday 24th October 2024.
Come to the The Cambridge Building Restaurant from 10am - 3pm.
During the demonstration day, so you can see examples of:
- Our new sterile, ready to use glass vial pack formats
- The latest in butyl rubber sealing solutions across vials, cartridges and pre-filled syringes
- Our new sterile vial adapters for reconstitution of drug formulations.
BioPORTER® protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.
Applications are invited for a Business Development Manager to join the Business Development department at Quadram Institute Bioscience (QIB), based in Norwich, UK.
Background:
Patents directed to polymorphs of pharmaceutical compounds can be of significant commercial importance. However, care needs to be taken both during drafting and prosecution to increase the chance of success at the European Patent Office. This webinar will discuss some of the issues faced for patent applications for polymorphs and how those issues can be addressed at the EPO, as well as looking at some recent case law.
Topics will include:
Neurodegenerative disorders affect the structure and function of the central nervous system, leading to the progressive loss of cognitive, motor, and sensory abilities. They include Alzheimer's disease, Parkinson’s disease, motor neuron disease, multiple sclerosis, Huntington’s disease, stroke and traumatic brain injury.